CYSTINE TRYPTIC AGAR W/DEXTROSE— 510(k) K844542

Substantially Equivalent

bioMerieux, Inc.

FDA 510(k) clearance K844542 for CYSTINE TRYPTIC AGAR W/DEXTROSE, Substantially Equivalent on 1985-01-16. Applicant: bioMerieux, Inc..

Clearance details

Applicant: bioMerieux, Inc.
Product code: Code JSF
Advisory panel: Microbiology
Date received: 1984-11-21
Decision date: 1985-01-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Addison, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.